Multiphasic compositions
The present invention relates to compositions comprising a colloidal dispersion and an Agent of Interest (“AOI”), wherein the colloidal dispersion comprises deformable colloidal particles and wherein the AOI is not associated with the deformable colloidal particles. The present invention also provides kits and transdermal drug release devices comprising the compositions of the present invention, and the use of these compositions in medicine, skin care and cosmetics.
1. A composition comprising a colloidal dispersion and an Agent of Interest (“AOI”), wherein said colloidal dispersion comprises deformable colloidal particles comprising a surfactant and a phospholipid and wherein the AOI is not associated with the deformable colloidal particles, wherein the AOI comprises a biologically active agent, wherein the AOI comprises capsaicin.
2. The composition of claim 1 wherein the deformable colloidal particles comprise vesicles.
3. The composition of claim 1 , wherein the capsaicin is present in the composition in the form of aggregates or wherein the capsaicin is associated with liposomes comprising one or more phospholipids.
4. The composition of claim 1 , wherein the deformable colloidal particles comprise menthol in their membranes.
5. The composition of claim 1 wherein the phospholipid is selected from the group consisting of sphingomyelin, sphingomyelin lauroyl, phosphatidyl choline and phosphatidyl glycerol.
6. The composition of claim 1 wherein the surfactant is a non-ionic surfactant, optionally wherein the surfactant is polyoxyethylene (20) sorbitan monooleate (Polysorbate 80) or 2-[(Z)-octadec-9-enoxy]ethanol.
7. The composition of claim 1 wherein the composition comprises a phospholipid and a surfactant in a molar ratio of 1:30 to 30:1.
8. A kit comprising a container comprising the composition of claim 1 and instructions for administration of the composition to a patient in need thereof, wherein the composition is contained within a single compartment of said container.